Pharmafile Logo

Disconnected pharma: Navigating digital challenges and priorities in 2024

We are delighted to present Graphite’s research whitepaper for 2024 — and this year we are able to share the challenges and priorities that digital leaders are finding, in this most interesting of seasons.

- PMLiVE

In our new whitepaper, we share the current challenges and priorities that digital pharma leaders are finding in 2024.

Connectivity underpins innovation and efficiency, enabling improved outcomes for patients and HCPs.

Our latest research reveals the need for increased connection across the pharma sector — linking data with actionable insights, joining up internal teams, improving interactions between end users and providers, connecting digital systems and platforms, and aligning long-term goals with short-term priorities.

Drawing on the survey data, along with opinions from expert contributors and Graphite’s own sector experience, we explore how pharma teams can overcome challenges to achieve success with their digital solutions and strategies.

Based on first-hand insight from pharma leaders working within Commercial, Medical, Marketing and Digital roles across the USA and Europe.

This content was provided by Graphite Digital

Company Details

 Latest Content from  Graphite Digital 

What do HCPs want from pharma medical information sites in 2026?

At Graphite, we regularly carry out first-hand research with healthcare professionals (HCPs) to understand how they interact with digital experiences in practice. When you combine those conversations with wider sector...

Bridging the value gap: The systems, teams and mindsets that matter

In pharma, the challenge is no longer understanding what HCPs want from digital. It’s delivering it consistently. In this webinar, we explored what needs to change inside organisations to make...

Webinar: What do HCPs really want from pharma digital in 2026?

Our research shows that healthcare professionals are not disengaging from pharma digital. They are becoming more selective about the experiences that earn their attention. To explore what this means for...

The strategic role of AI in scaling Design Systems across channels

How can pharma teams scale AI safely across channels? In this session, Ed Hart and Nicolas Barcza explore why strong Design Systems are the foundation for making AI operational, compliant...

What HCPs want from digital pharma in 2026: The value gap

We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the value gap is widening.

First impressions matter: Why getting your onboarding right is key for digital engagement

As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,...

Pharma’s digital dilemma: Finding the balance between speed, scale, and experience

What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick...

Redefining digital ROI: Engagement, experience, and the new metrics of success

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and...

5 key digital CX challenges in pharma, and how to start solving them

Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are...

The digital reality check: How pharma measures up in 2025

Download your copy of our latest pharma white paper, exploring the latest digital trends, challenges and opportunities in pharma.